Torrent Pharmaceuticals

₹4,750As of Sun 8 Nov 2026, 12:00 UTC

NSE:TORNTPHARMHealthcare

Country India

PE (Fwd) 61.53

TSR 10Y CAGR 22.37%

Div yield 0.80%

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 0.17

PE TTM 74.31

TSR TTM 34.61%

Mkt cap ₹1.819T

ROIC —

SE Grade™

Value

Quality

Moat

—

1Y Price

Reference

₹5,160

8.64%

(79.42%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

139.8

Revenue₹B

—

85.08

96.20

107.3

115.2

139.8

153.4

13.22%

21.39

Revenue growth%

—

13.07

11.51

7.35

21.39

9.72

12.29

—

75.76

Gross margin%

—

71.30

71.57

74.96

75.90

75.76

75.77

74.96

24.61

Operating margin%

—

20.80

22.25

23.98

25.41

24.61

24.65

23.98

15.48

Net margin%

—

9.13

12.94

15.44

16.60

15.48

15.59

15.44

74.31

P/E ratio (avg)x

—

62.86

41.15

41.99

55.67

57.93

67.21

55.67

46.74

EV/EBITx

—

27.61

23.95

27.04

36.36

36.44

42.52

27.61

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

63.92

EPS₹

—

22.96

36.79

48.94

56.47

63.92

70.67

29.17%

—

13.19

EPS growth%

—

60.22

33.02

15.39

13.19

10.56

24.20

—

Bookvalue per sh₹

—

FCF per share₹

—

38.00

Dividend per sh₹

—

16.50

22.00

28.00

32.00

38.00

40.43

23.19%

—

0.80

Div yield (avg)%

—

1.14

1.45

1.36

1.02

1.03

0.85

1.14

59.45

Payout ratio%

—

71.85

59.79

57.21

56.67

59.45

57.22

59.45

338.4

Shares (diluted)M

—

338.4

◌338.4

—

Buyback yield%

—

◌—

—

D/E ratiox

—

1,608

Enterprise value₹B

—

488.5

512.4

695.6

1,064

1,253

1,608

26.56%

—

LT debt₹M

—

Peers (US$19.20B)

Cap (US$)

Divi's Laboratories…

29.17B

81.44x

Laurus Labs Limited

13.46B

94.44x

Zydus Lifesciences…

12.72B

28.64x

Swedish Orphan…

17.53B

26.50x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

8.942

7.295

Own earn%

—

Sh yield%

0.80

1.19

Owners

Insiders/Inst%

—

19.96

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

5/5

Revenue growth years

4/4

EPS growth years

4/4

Dividend streakyrs

Op margin range%

21–25

$1 testx

—

Incr. ROIC%

—

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹139.8B

13.22%

1.00×

Cost of revenue

₹33.88B

8.53%

0.84×

Operating expenses

₹71.52B

13.58%

1.01×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m